It is consistently observed that levels of BACE1 protein and activity are elevated in the brains of AD patients [19]–[23] and APP transgenic (Tg) mice [22], [24]–[26], suggesting that increased BACE1 could have a role in the development and/or progression of AD by exacerbating Aβ generation. Here, APP is linked to Alzheimer disease.